ArticleDisease markers2019

Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention.

Zi-Wen Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.